{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:40:32Z","timestamp":1743104432182,"version":"3.37.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"55","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The growing use of oral systemic therapies and transition of some cancer treatments to the outpatient setting makes capturing all cancer case patients more difficult. We aim to develop algorithms to identify potentially missed incident case patients and estimate impact on incidence rates. We reviewed claims from SEER-Medicare 5% noncancer\u00a0control patient sample to identify potentially missed chronic myeloid leukemia (CML) and bladder case patients based on diagnosis codes, cancer-related treatments, and oncology consultations. Observed rates of definite missed CML and definite and probable missed bladder case patients were calculated and the impact of missed case patients of these two cancers on SEER 65+ incidence rates were estimated. From 2008 to 2015, the algorithm estimated 781 definite CML case patients missed, increasing the number by 10.7%. From 2007 to 2015, the algorithm estimated 4629 definite and 5772 probable bladder case patients missed, increasing the number by 3.8% to 8.1%. Our algorithms offer potential methods for identifying missed case patients and validating the completeness of cancer registries.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgz033","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T04:33:38Z","timestamp":1575520418000},"page":"31-38","source":"Crossref","is-referenced-by-count":4,"title":["Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries"],"prefix":"10.1093","volume":"2020","author":[{"given":"Clara J K","family":"Lam","sequence":"first","affiliation":[{"name":"Data Analytics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan L","family":"Warren","sequence":"additional","affiliation":[{"name":"Healthcare Assessment Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Nielsen","sequence":"additional","affiliation":[{"name":"UNC Department of Urology Oncology, UNC Lineberger Cancer Center, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Smith","sequence":"additional","affiliation":[{"name":"UNC Department of Urology Oncology, UNC Lineberger Cancer Center, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boyd","sequence":"additional","affiliation":[{"name":"Information Management Services, Inc., Calverton, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Barrett","sequence":"additional","affiliation":[{"name":"Information Management Services, Inc., Calverton, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela B","family":"Mariotto","sequence":"additional","affiliation":[{"name":"Data Analytics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"issue":"8","key":"2021020712452875200_lgz033-B1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10552-012-0003-1","article-title":"Hematologic malignancies: an opportunity to fill a gap in cancer surveillance","volume":"23","author":"Penberthy","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2021020712452875200_lgz033-B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1377\/hlthaff.28.1.26","article-title":"Use of medical care for chronic conditions","volume":"28","author":"Decker","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"2021020712452875200_lgz033-B3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2005.03.5840","article-title":"Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000","volume":"24","author":"Harlan","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021020712452875200_lgz033-B4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hon.747","article-title":"Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin\u2019s lymphoma","volume":"23","author":"Cronin","year":"2005","journal-title":"Hematol Oncol"},{"issue":"5","key":"2021020712452875200_lgz033-B5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/01.ju.0000056727.30546.b7","article-title":"Patterns of care for the treatment of bladder cancer","volume":"169","author":"Snyder","year":"2003","journal-title":"J Urol"},{"key":"2021020712452875200_lgz033-B6","first-page":"IV","article-title":"Utility of SEER-Medicare data to identify chemotherapy use","volume":"40(suppl","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"7","key":"2021020712452875200_lgz033-B7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2002.07.052","article-title":"Adjuvant therapy for breast cancer: practice patterns of community physicians","volume":"20","author":"Harlan","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021020712452875200_lgz033-B8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1055-9965.EPI-07-2620","article-title":"Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among Medicare enrollees in fee for service","volume":"17","author":"Schenck","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2021020712452875200_lgz033-B9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.EPI-03-0250","article-title":"Expert review of non-Hodgkin\u2019s lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classification","volume":"13","author":"Clarke","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"2021020712452875200_lgz033-B10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.leukres.2009.06.013","article-title":"High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort","volume":"33","author":"Seftel","year":"2009","journal-title":"Leuk Res"},{"issue":"5","key":"2021020712452875200_lgz033-B11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/1097-0142(20010901)92:5<1325::AID-CNCR1454>3.0.CO;2-E","article-title":"Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data","volume":"92","author":"Zent","year":"2001","journal-title":"Cancer"},{"issue":"26","key":"2021020712452875200_lgz033-B12","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2021020712452875200_lgz033-B13","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.22912","article-title":"Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003","volume":"121","author":"Turesson","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"2021020712452875200_lgz033-B14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1600-0609.2002.01544.x","article-title":"Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway: the Tromso Study","volume":"69","author":"Skjelbakken","year":"2002","journal-title":"Eur J Haematol"},{"issue":"5-6","key":"2021020712452875200_lgz033-B15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/10428190109060346","article-title":"Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Sweden population","volume":"41","author":"Astrom","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2021020712452875200_lgz033-B16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.6004\/jnccn.2018.0071","article-title":"Chronic myeloid leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Radich","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"2021020712452875200_lgz033-B17","first-page":"141","article-title":"Impact of automated data collection from urology offices: improving incidence and treatment reporting in urologic cancers","volume":"37","author":"Penberthy","year":"2010","journal-title":"J Registry Manag"},{"key":"2021020712452875200_lgz033-B18","first-page":"IV3","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40(suppl","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"2021020712452875200_lgz033-B19"},{"key":"2021020712452875200_lgz033-B20"},{"issue":"9","key":"2021020712452875200_lgz033-B21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.6004\/jnccn.2018.0072","article-title":"NCCN guidelines insights: bladder cancer, version 5.2018","volume":"16","author":"Flaig","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"year":"2019","key":"2021020712452875200_lgz033-B22"},{"issue":"4","key":"2021020712452875200_lgz033-B23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3322\/caac.21400","article-title":"The burden of rare cancers in the United States","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2021020712452875200_lgz033-B24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","article-title":"Role of tyrosine kinase inhibitors in cancer therapy","volume":"315","author":"Arora","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2021020712452875200_lgz033-B25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2014.04.008","article-title":"Ambulatory surgery centers and outpatient urologic surgery among Medicare beneficiaries","volume":"84","author":"Suskind","year":"2014","journal-title":"Urology"},{"key":"2021020712452875200_lgz033-B26"},{"issue":"1","key":"2021020712452875200_lgz033-B27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006","volume":"120","author":"Nielsen","year":"2014","journal-title":"Cancer"},{"year":"2002","key":"2021020712452875200_lgz033-B28"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jncimono\/article-pdf\/2020\/55\/31\/36208827\/lgz033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jncimono\/article-pdf\/2020\/55\/31\/36208827\/lgz033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:01:06Z","timestamp":1612810866000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2020\/55\/31\/5837294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":28,"journal-issue":{"issue":"55","published-online":{"date-parts":[[2020,5,15]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgz033","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"type":"print","value":"1052-6773"},{"type":"electronic","value":"1745-6614"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,5,1]]}}}